FACSLyric

Device Becton, Dickinson and Company
Total Payments
$249,062
Transactions
17
Doctors
2
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2022 $200,050 15 2
2021 $48,826 1 0
2020 $186.95 1 0

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $247,164 7 99.2%
Travel and Lodging $1,601 8 0.6%
Food and Beverage $298.44 2 0.1%

Payments by Type

Research
$247,164
7 transactions
General
$1,899
10 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
LYRICLEUMC Becton, Dickinson and Company $198,151 0
Lean Workflow Analysis Becton, Dickinson and Company $49,013 0

Top Doctors Receiving Payments for FACSLyric

Doctor Specialty Location Total Records
Unknown Boston, MA $247,164 7
, M.D Anatomic Pathology & Clinical Pathology Little Rock, AR $1,456 6
, M.D Anatomic Pathology & Clinical Pathology Euclid, OH $442.86 4

About FACSLyric

FACSLyric is a device associated with $249,062 in payments to 2 healthcare providers, recorded across 17 transactions in the CMS Open Payments database. The primary manufacturer is Becton, Dickinson and Company.

Payment data is available from 2020 to 2022. In 2022, $200,050 was paid across 15 transactions to 2 doctors.

The most common payment nature for FACSLyric is "Unspecified" ($247,164, 99.2% of total).

FACSLyric is associated with 2 research studies, including "LYRICLEUMC" ($198,151).